首页 | 本学科首页   官方微博 | 高级检索  
检索        


Epirubicin-mediated expression of miR-302b is involved in osteosarcoma apoptosis and cell cycle regulation
Authors:Yi Zhang  Hao Hu  Lu Song  Lin Cai  Renxiong Wei  Wei Jin
Institution:1. Department of Orthopedics, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China;2. Department of Orthopedics, Wuhan General Hospital of Guangzhou Command, Wuhan, Hubei, China;3. Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China
Abstract:Epirubicin is widely used in osteosarcoma chemotherapy. Growing evidence indicates that the microRNA (miRNA) expression levels which are induced by chemotherapeutic agents play an important role in osteosarcoma development and progression. In this study we investigate the alterations of miRNA expression in the osteosarcoma cells after epirubicin treatment and whether miRNAs can enhance its anti-osteosarcoma effect. After epirubicin exposure, microarray shows 40 miRNAs are differentially expressed in osteosarcoma cells including 24 down-regulated miRNAs. Notably, miR-302b, which is stably low-expressed in osteosarcoma, could be induced by the epirubicin. Furthermore, we find that miR-302b can inhibit the osteosarcoma cell proliferation, promote cell apoptosis and cell cycle arrest MiR-302b can activate caspase-3 and regulate the Akt/pAkt, Bcl-2, Bim expression to increase the cell apoptosis. Meanwhile, miR-302b also attenuates cyclin D1 and CDKs expression to induce cell cycle arrest. Therefore, our results suggest miR-302b can play an essential role in osteosarcoma treatment as a potential tumor suppressor.
Keywords:Osteosarcoma  Microrna  Mirna-302b  Epirubicin
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号